ESC Premium Access

Advances in revascularisation strategies in patients with multivessel disease

Event: ESC CONGRESS 2019
Topic: Percutaneous Coronary Intervention (PCI)
Session type: Advances in Science
Date: 1 September 2019
Time: 08:30 - 10:00


5 presentations in this session

State of the Art - Ten years after syntax: a surgeon's perspective

Speaker: Professor M. Borger (Leipzig, DE)

FFR guided acute complete revascularization versus culprit lesion only treatment in patients presenting with STEMI and multi vessel disease; final 3-year outcome data from Compare-Acute trial

Speaker: Doctor P. Smits (Rotterdam, NL)

Prognostic impact of SYNTAX Score in patients with myocardial infarction with multivessel coronary artery disease and cardiogenic shock: insight from the CULPRIT-SHOCK Trial

Speaker: Doctor P. Guedeney (Paris, FR)

Coronary artery bypass grafting vs. FFR-guided PCI in diabetic patients with multivessel disease

Speaker: Doctor G. Di Gioia (Mercogliano, IT)

Percutaneous coronary intervention in 2030: overcoming current PCI limitations

Speaker: Doctor A. Colombo (Milan, IT)

5 speakers from this session

Professor Michael A Borger

University of Leipzig, Heart Center, Department of Cardiac Surgery, Leipzig (Germany)
11 presentations
0 follower

Doctor Pieter C Smits

Maasstad Hospital, Rotterdam (Netherlands (The))
4 presentations
0 follower

Doctor Paul Guedeney

Hospital Pitie-Salpetriere, Paris (France)
0 follower

Doctor Giuseppe Di Gioia

Montevergine Clinic, Mercogliano (Italy)
1 presentation
0 follower

Doctor Antonio Colombo

EMO-GVM Heart Center Columbus, Milan (Italy)
10 presentations
0 follower

This platform is supported by

logo Novo Nordisk